Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with 
positron emission tomography (PET): A dose ranging study with the reversible 
inhibitor Ro 19-6327

Bench, C. J.; Price, G. W.; Lammertsma, A. A.; Cremer, J. C.; Luthra, S. K.; Turton, D.; Dolan, Raymond J.; Kettler, R.; Dingemanse, J.; Da Prada, M.; Biziere, K.; McClelland, G. R.; Jamieson, V. L.; Wood, N. D.; Frackowiak, R. S. J.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): A dose ranging study with the reversible inhibitor Ro 19-6327

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

RD_Measurement_1991.pdf
(Publisher version), 523KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Bench, C. J., Price, G. W., Lammertsma, A. A., Cremer, J. C., Luthra, S. K., Turton, D., et al. (1991). Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): A dose ranging study with the reversible inhibitor Ro 19-6327. European Journal of Clinical Pharmacology, 40, 169-173.

Cite as: https://hdl.handle.net/21.11116/0000-0001-A385-0

Abstract

There is no abstract available